Could Temperamental Features Modulate Participation in Clinical Trials?

Could Temperamental Features Modulate Participation in Clinical Trials?

The prodromal stages of Alzheimer’s disease (AD) are the primary focus of research aimed at slowing disease progression. This study explores the influence of affective temperament on the motivation of people with mild cognitive impairment (MCI) and subjective cognitive decline (SCD) to participate i...

Full description

Bibliographic Details
Main Authors: Simona Cintoli, Camilla Elefante, Claudia Radicchi, Giulio Emilio Brancati, Silvia Bacciardi, Joyce Bonaccorsi, Gabriele Siciliano, Icro Maremmani, Giulio Perugi, Gloria Tognoni
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Journal of Clinical Medicine
Subjects:
Alzheimer’ disease
mild cognitive impairment
subjective cognitive decline
temperament
clinical trials
recruitment
Online Access:https://www.mdpi.com/2077-0383/12/3/1121

Internet

https://www.mdpi.com/2077-0383/12/3/1121

Similar Items